Waleria Healthtech has reported positive results from a clinical trial of its Shatavari root extract, marketed as aspurūs, which indicates enhancements in sexual function and various wellbeing measures among reproductive-age women experiencing low sexual desire.
Read More
The findings were published in the Journal of Medicine and Life. The randomized, double-blind, placebo-controlled trial included 70 women aged 18 to 45 years in India.
Participants received either 300 mg of Shatavari extract or a placebo daily for eight weeks. The primary measure of outcome was the Female Sexual Function Index (FSFI), a validated tool for assessing sexual function.
At the end of the eight-week period, the total FSFI score in the Shatavari group showed a significant increase of 67.96%, compared to just 7.58% in the placebo group.
The researchers also noted improvements in sexual encounters, sleep disturbances, and fatigue levels. Specifically, scores on the Fatigue Severity Scale improved by 60.05% for those taking Shatavari, while those on placebo only saw a 4.45% improvement. Additionally, scores for sleep disturbances improved by 21.83% in the intervention group.
Participants reported that the extract was well tolerated throughout the trial.
The study specifically targeted women of reproductive age, excluding younger participants and those who were peri- or postmenopausal. Waleria founder Komal Baldwa emphasized that the research sought to explore sexual wellbeing along with related factors such as fatigue, sleep, and physical comfort.
Aspurūs is a full-spectrum extract of Asparagus racemosus, commonly known as Shatavari, a plant used in Ayurvedic medicine. Waleria highlights its extraction process, which aims to maintain a broad phytochemical profile, including seven identified bioactives, with the ingredient standardized to contain five percent Shatavarins.
The company is interested in expanding the use of this ingredient for women's health applications across various life stages, including supplementary investigations into treating menopausal symptoms.
While these clinical trial results contribute to the body of research on botanicals for women’s sexual health and wellbeing, the authors caution that the relatively small size of the study and its single-center nature necessitate further research to validate these findings and assess their reproducibility.